CLINICAL_TRIALS
trial_result
· 2025-03-06
Clinical Trial Update: Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure
Summary
Clinical trial update for the antiviral Tecovirimat (ST-246) used to treat exposure to orthopoxviruses, including smallpox and monkeypox; the study status is AV…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: U.S. Army Medical Research and Development Command | Conditions: Smallpox, Monkeypox | Status: AVAILABLE